Robert Lew

2.1k total citations
68 papers, 1.7k citations indexed

About

Robert Lew is a scholar working on Cellular and Molecular Neuroscience, Surgery and Molecular Biology. According to data from OpenAlex, Robert Lew has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 25 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Robert Lew's work include Neurotransmitter Receptor Influence on Behavior (20 papers), Coronary Interventions and Diagnostics (18 papers) and Neuroscience and Neuropharmacology Research (17 papers). Robert Lew is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (20 papers), Coronary Interventions and Diagnostics (18 papers) and Neuroscience and Neuropharmacology Research (17 papers). Robert Lew collaborates with scholars based in United States, Australia and United Kingdom. Robert Lew's co-authors include Lewis S. Seiden, Jogeshwar Mukherjee, Georgetta Vosmer, Zhi-Ying Yang, Krishnankutty Sudhir, Tye Dawood, Maro R. I. Williams, Paul A. Komesaroff, Karen E. Sabol and Jerry B. Richards and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Robert Lew

66 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Lew United States 24 799 574 315 267 198 68 1.7k
R Arendt Germany 21 380 0.5× 256 0.4× 282 0.9× 278 1.0× 36 0.2× 59 1.5k
John P. Huggins United Kingdom 19 239 0.3× 422 0.7× 173 0.5× 104 0.4× 68 0.3× 28 1.6k
Peter Nguyen United States 16 323 0.4× 366 0.6× 60 0.2× 204 0.8× 90 0.5× 36 1.3k
Toyoki Mori Japan 28 405 0.5× 1.3k 2.3× 458 1.5× 300 1.1× 46 0.2× 101 3.4k
Julianne J. Reid Australia 21 268 0.3× 404 0.7× 279 0.9× 117 0.4× 14 0.1× 47 1.2k
W Horst United States 23 736 0.9× 514 0.9× 117 0.4× 120 0.4× 248 1.3× 70 1.8k
Jean‐Louis Imbs France 24 112 0.1× 263 0.5× 353 1.1× 101 0.4× 40 0.2× 80 1.4k
I. Mhairi Macrae United Kingdom 23 470 0.6× 557 1.0× 185 0.6× 85 0.3× 130 0.7× 52 2.0k
Md. Shenuarin Bhuiyan United States 28 314 0.4× 1.3k 2.3× 509 1.6× 73 0.3× 29 0.1× 82 2.2k
Takafumi Nagatomo Japan 19 461 0.6× 733 1.3× 265 0.8× 109 0.4× 55 0.3× 138 1.4k

Countries citing papers authored by Robert Lew

Since Specialization
Citations

This map shows the geographic impact of Robert Lew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lew more than expected).

Fields of papers citing papers by Robert Lew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lew. The network helps show where Robert Lew may publish in the future.

Co-authorship network of co-authors of Robert Lew

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Lew. A scholar is included among the top collaborators of Robert Lew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Lew. Robert Lew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lew, Robert, Gerald R. Galluppi, Yu‐Luan Chen, et al.. (2025). An open‐label study on ulotaront's effects on insulin‐glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I. Diabetes Obesity and Metabolism. 28(1). 103–111.
2.
Milanović, Snežana, Nina Dedic, Robert Lew, et al.. (2024). TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes. Diabetes Obesity and Metabolism. 26(6). 2466–2475. 3 indexed citations
3.
Szabo, Steven T., Seth C. Hopkins, Robert Lew, et al.. (2023). A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy. Sleep Medicine. 107. 202–211. 5 indexed citations
4.
Htun, Nay, et al.. (2021). Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial. Circulation Cardiovascular Interventions. 14(5). e009992–e009992. 43 indexed citations
5.
Lew, Robert, Cristian Constantinescu, Daniel Holden, et al.. (2020). The rate of dasotraline brain entry is slow following intravenous administration. Psychopharmacology. 237(11). 3435–3446. 2 indexed citations
6.
Shaw, J., Nick Andrianopoulos, Stephen J. Duffy, et al.. (2008). Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovascular revascularization medicine. 9(4). 218–223. 25 indexed citations
7.
Yan, Bryan P., Ronen Gurvitch, Stephen J. Duffy, et al.. (2007). An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheterization and Cardiovascular Interventions. 70(7). 928–936. 38 indexed citations
8.
Williams, Maro R. I., Tye Dawood, Shanhong Ling, et al.. (2004). Dehydroepiandrosterone Increases Endothelial Cell Proliferationin Vitroand Improves Endothelial Functionin Vivoby Mechanisms Independent of Androgen and Estrogen Receptors. The Journal of Clinical Endocrinology & Metabolism. 89(9). 4708–4715. 113 indexed citations
9.
Sharma, Arvind, Andrew E. Ajani, Robert Lew, et al.. (2003). Totally occluded in-stent restenotic lesions treated with gamma intracoronary radiation: Six-month clinical and angiographic outcomes. Journal of the American College of Cardiology. 41(6). 37–37. 1 indexed citations
10.
Mukherjee, Jogeshwar, Zhi-Ying Yang, Robert Lew, et al.. (1997). Evaluation ofd-amphetamine effects on the binding of dopamine D-2 receptor radioligand,18F-fallypride in nonhuman primates using positron emission tomography. Synapse. 27(1). 1–13. 74 indexed citations
11.
Lew, Robert, Karen E. Sabol, Chung‐Kwang Chou, et al.. (1996). Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 855–865. 76 indexed citations
12.
Tafuri, Agostino, William E. Bowers, Eugene S. Handler, et al.. (1993). High stimulatory activity of dendritic cells from diabetes-prone BioBreeding/Worcester rats exposed to macrophage-derived factors.. Journal of Clinical Investigation. 91(5). 2040–2048. 8 indexed citations
13.
Lew, Robert, Amrat Patel, Roxanne A. Vaughan, Alan A. Wilson, & M J Kuhar. (1992). Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens. Brain Research. 584(1-2). 266–271. 44 indexed citations
14.
Lew, Robert, et al.. (1991). Dopamine transporter: deglycosylation with exo- and endoglycosidases. Brain Research. 539(2). 239–246. 43 indexed citations
15.
Lew, Robert, Roxanne A. Vaughan, Rabi Simantov, Alan A. Wilson, & M. J. Kuhar. (1991). Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights. Synapse. 8(2). 152–153. 62 indexed citations
16.
Becker, Richard C., Christopher A. Clyne, Bonnie H. Weiner, et al.. (1991). Heparin Pharmacokinetics and in vitro Anticoagulant Activity in Patients Receiving Nonionic Radiographic Contrast Media. Cardiology. 79(1). 31–38.
17.
Recht, Lawrence D., Gitte Strauss, Thomas J. FitzGerald, et al.. (1990). Preirradiation Chemotherapy of Supratentorial Malignant Primary Brain Tumors with Intracarotid cis-Platinum (CDDP) and i.v. BCNU. American Journal of Clinical Oncology. 13(2). 125–131. 31 indexed citations
18.
Lew, Robert, DP Geraghty, Guy Drapeau, D. Regoli, & Elizabeth Burcher. (1990). Binding characteristics of [125I]Bolton-Hunter [Sar9, Met(O2)11]substance P, a new selective radioligand for the NK1 receptor. European Journal of Pharmacology. 184(1). 97–108. 59 indexed citations
19.
Kuhar, Michael J., et al.. (1990). Dopamine Transporter: Biochemistry, Pharmacology and Imaging. European Neurology. 30(1). 15–20. 72 indexed citations
20.
Geraghty, DP, et al.. (1989). Effect of capsaicin pretreatment on NK1 receptors in guinea-pig lung. eCite Digital Repository (University of Tasmania). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026